[New trends in treatment of hypertrophic cardiomyopathy].
The management of patients with hypertrophic cardiomyopathy has largely evolved over the past two decades. One important finding is that medical treatment appears under used. Invasive procedure are reserved to patients with obstructive hypertrophic cardiomyopathy who remain symptomatic despite optimal medical treatment. Indications for implantable cardiac defibrillator are still debated. A global and multidisciplinary approach of the patient and of his family is mandatory.
Moonen
Marie L
ML
Service de cardiologie, CHU Sart Tilman B35, 4000 Liège, Belgique. m.moonen@ulg.ac.be
Piérard
Luc A
LA
D002312:Cardiomyopathy, Hypertrophic / Q000209:etiology / Q000628:therapy*; D003645:Death, Sudden / Q000517:prevention & control; D006801:Humans; D012307:Risk Factors